Orion
36,39EUR -0,71%13.241 investorer følger denne virksomhed
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo.
P/E (23e)
28
EV/EBIT (adj.) (23e)
20,67
P/B (23e)
5,9
Udbytteafkast, % (23e)
4,53 %
Kursmål
42.00 EUR
Anbefaling
Akkumulér
Opdateret
27.10.2023
NASDAQ Helsinki
ORNBV
Daglig lav / høj pris
35,91 / 36,65
EUR
Markedsværdi
5,14 mia. EUR
Aktieomsætning
3,18 mio. EUR
Volumen
88 t
Risiko og anbefaling
HøjRisikoLav
SælgAnbefalingKøb
Analyst
Antti Siltanen
Analytiker
Pauli Lohi
Analytiker
Seneste videoer
Finanskalender
Årsrapport
13.02.2024
Generalforsamling
20.03.2024
Delårsrapport
25.04.2024
Delårsrapport
08.08.2024
Delårsrapport
29.10.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Ilmarinen Mutual Pension Insurance Company | 2,7 % | 4,9 % |
| Varma Mutual Pension Insurance Company | 2,4 % | 0,4 % |
Premium
Not activated
This content is for our Premium customers only.
Insider Transactions
| Insider | Date | Total value |
|---|---|---|
| Mikael Silvennoinen | 15.11.2023 | 72.313EUR |
| Mikael Silvennoinen | 15.11.2023 | 44.782EUR |
Premium
Not activated
This content is for our Premium customers only.
Resultatopgørelse
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| Omsætning | 1.051,00 | 1.078,10 | 1.041,10 | 1.340,60 | 1.172,65 | 1.293,91 | 1.439,09 | 1.582,99 |
| vækst-% | 7,52 % | 2,58 % | -3,43 % | 28,77 % | -12,53 % | 10,34 % | 11,22 % | 10,00 % |
| EBITDA | 308,90 | 336,50 | 289,04 | 486,60 | 284,72 | 315,75 | 362,23 | 411,40 |
| EBIT (adj.) | 252,80 | 280,10 | 243,34 | 439,60 | 234,12 | 278,19 | 323,79 | 372,00 |
| EBIT | 252,80 | 280,10 | 243,34 | 439,60 | 234,12 | 278,19 | 323,79 | 372,00 |
| Overskud før skat | 250,84 | 278,30 | 242,34 | 440,30 | 231,27 | 276,89 | 321,22 | 368,57 |
| Netto indkomst | 200,36 | 219,85 | 193,79 | 349,50 | 182,58 | 218,74 | 253,77 | 291,17 |
| EPS (adj.) | 1,42 | 1,57 | 1,38 | 2,49 | 1,30 | 1,56 | 1,81 | 2,07 |
| vækst-% | 1,54 % | 9,91 % | -11,85 % | 80,35 % | -47,76 % | 19,81 % | 16,01 % | 14,74 % |
| Udbytte | 1,50 | 1,50 | 1,50 | 1,60 | 1,65 | 1,70 | 1,80 | 1,90 |
| Udbytte ratio | 105,33 % | 95,84 % | 108,72 % | 64,30 % | 126,94 % | 109,17 % | 99,63 % | 91,66 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 29,39 % | 31,21 % | 27,76 % | 36,30 % | 24,28 % | 24,40 % | 25,17 % | 25,99 % |
| EBIT-% (adj.) | 24,05 % | 25,98 % | 23,37 % | 32,79 % | 19,97 % | 21,50 % | 22,50 % | 23,50 % |
| EBIT-% | 24,05 % | 25,98 % | 23,37 % | 32,79 % | 19,97 % | 21,50 % | 22,50 % | 23,50 % |
| ROE | 25,81 % | 29,11 % | 26,81 % | 43,08 % | 20,59 % | 25,45 % | 29,50 % | 32,83 % |
| ROI | 29,52 % | 34,41 % | 29,54 % | 45,56 % | 23,04 % | 29,56 % | 32,14 % | 34,47 % |
Værdiansættelse
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 41,27 | 37,53 | 36,52 | 51,24 | 36,39 | 36,39 | 36,39 | 36,39 |
| Aktier | 140,70 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 |
| Markedsværdi | 5.806,50 | 5.271,57 | 5.129,70 | 7.197,31 | 5.111,44 | 5.111,44 | 5.111,44 | 5.111,44 |
| Enterprise value | 5.667,50 | 5.085,78 | 4.940,34 | 7.078,71 | 4.838,26 | 4.877,00 | 4.896,02 | 4.888,70 |
| EV/S | 5,39 | 4,72 | 4,75 | 5,28 | 4,13 | 3,77 | 3,40 | 3,09 |
| EV/EBITDA | 18,35 | 15,11 | 17,09 | 14,55 | 16,99 | 15,45 | 13,52 | 11,88 |
| EV/EBIT (adj.) | 22,42 | 18,16 | 20,30 | 16,10 | 20,67 | 17,53 | 15,12 | 13,14 |
| EV/EBIT | 22,42 | 18,16 | 20,30 | 16,10 | 20,67 | 17,53 | 15,12 | 13,14 |
| P/E (adj.) | 28,98 | 23,98 | 26,47 | 20,59 | 28,00 | 23,37 | 20,14 | 17,55 |
| P/E | 28,98 | 23,98 | 26,47 | 20,59 | 28,00 | 23,37 | 20,14 | 17,55 |
| P/B | 7,45 | 7,21 | 7,18 | 7,93 | 5,90 | 5,99 | 5,89 | 5,64 |
| P/S | 5,52 | 4,89 | 4,93 | 5,37 | 4,36 | 3,95 | 3,55 | 3,23 |
| Udbytteprocent | 3,63 % | 4,00 % | 4,11 % | 3,12 % | 4,53 % | 4,67 % | 4,95 % | 5,22 % |
| Equity ratio | 75,25 % | 65,56 % | 66,03 % | 60,39 % | 68,02 % | 63,20 % | 60,45 % | 59,68 % |
| Gearing ratio | -17,83 % | -25,41 % | -26,51 % | -13,06 % | -31,55 % | -27,49 % | -24,82 % | -24,58 % |
Kvartalsdata
| Q4/22 | 2022 | Q1/23 | Q2/23 | Q3/23 | Q4/23e | 2023e | Q1/24e | Q2/24e | |
|---|---|---|---|---|---|---|---|---|---|
| Omsætning | 294,50 | 1.340,60 | 277,90 | 289,60 | 301,00 | 304,15 | 1.172,65 | ||
| EBITDA | 53,23 | 486,60 | 67,67 | 59,43 | 92,71 | 64,92 | 284,72 | ||
| EBIT | 40,70 | 439,60 | 55,47 | 46,63 | 79,91 | 52,12 | 234,12 | ||
| Overskud før skat | 40,50 | 440,30 | 55,13 | 46,38 | 79,66 | 51,87 | 231,27 | ||
| Netto indkomst | 31,70 | 349,50 | 43,83 | 36,64 | 62,93 | 40,98 | 182,58 |
ViserAlle indholdstyper
